| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.5M | — | +26.9% |
| Cost of Revenue | $10.9M | — | +26.4% |
| Gross Profit | $8.6M | — | +27.6% |
| R&D Expense | $797K | — | +20.0% |
| SG&A Expense | $1.2M | — | +19.5% |
| Operating Income | $2.3M | — | +62.2% |
| Pre-tax Income | $2.4M | — | +58.3% |
| Income Tax | $622K | — | +59.3% |
| Net Income | $1.8M | — | +57.9% |
| EPS (Basic) | $0.28 | — | +55.6% |
| EPS (Diluted) | $0.27 | — | +58.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.0M | +31.0% | +34.0% |
| Accounts Receivable | $6.3M | -20.8% | -1.9% |
| Inventory | $16.4M | -21.7% | -3.4% |
| Current Assets | $45.6M | -4.3% | +13.3% |
| Total Assets | $49.6M | -4.8% | +9.3% |
| Current Liabilities | $5.6M | -43.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.6M | — | +492.4% |
| Investing Cash Flow | -$166K | — | +8.0% |
| Financing Cash Flow | -$330K | — | -9.4% |
| +0.2% |
| Total Liabilities | $5.6M | -43.4% | -3.8% |
| Stockholders' Equity | $44.0M | +4.2% | +11.2% |